IFPMA represents research-based biopharmaceutical companies and associations worldwide, fostering collaboration and dialogue within the industry and with other health community players. They strive to promote innovation, resilient regulatory systems, high quality standards, ethical practices, and sustainable health policies. As a credible voice in global health conversations, IFPMA addresses the challenges in public health policy for current and future generations. With official relations with the United Nations, IFPMA utilizes industry expertise to contribute to finding solutions that improve global health.